2022 Q3 Form 10-Q Financial Statement

#000182912622015807 Filed on August 15, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q2 2022 Q1
Revenue $24.24M $0.00 $0.00
YoY Change
Cost Of Revenue $14.82M $41.20M $13.43M
YoY Change -15.97% 79.13% -68.55%
Gross Profit $9.420M $57.30M $10.79M
YoY Change -74.12% -35.55% -82.99%
Gross Profit Margin 38.86%
Selling, General & Admin $879.9K $8.600M $684.6K
YoY Change -89.03% 38.71% -80.98%
% of Gross Profit 9.34% 15.01% 6.35%
Research & Development $6.892M $34.20M $6.553M
YoY Change -64.78% -38.93% -83.15%
% of Gross Profit 73.16% 59.69% 60.75%
Depreciation & Amortization $710.0K $1.600M $1.700M
YoY Change -58.24% 0.0% 0.0%
% of Gross Profit 7.54% 2.79% 15.76%
Operating Expenses -$8.393M $122.9K $258.4K
YoY Change -2220.16% -14.23% 355.14%
Operating Profit $1.027M $57.18M $3.276M
YoY Change -84.61% -35.58% -94.83%
Interest Expense -$20.00K $44.57K $990.00
YoY Change -3433.33% 63571.43% -100.99%
% of Operating Profit -1.95% 0.08% 0.03%
Other Income/Expense, Net $31.94K $19.09K -$52.41K
YoY Change 3093.5% 27976.47%
Pretax Income $1.718M -$103.8K -$309.9K
YoY Change -535.6% -27.52% 445.7%
Income Tax $57.31K
% Of Pretax Income 3.34%
Net Earnings $1.660M -$103.8K -$309.8K
YoY Change -521.06% -27.52% 445.71%
Net Earnings / Revenue 6.85%
Basic Earnings Per Share
Diluted Earnings Per Share $0.03 -$13.92K -$41.55K
COMMON SHARES
Basic Shares Outstanding 7.458M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2022 Q3 2022 Q2 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $46.96M $0.00 $29.07K
YoY Change 130780.71% -100.0% 927.21%
Cash & Equivalents $46.96M $6.915M
Short-Term Investments $10.00M
Other Short-Term Assets $1.951M $170.00 $45.17K
YoY Change 1238.8% -89.82% 47.76%
Inventory $148.6K $1.800M
Prepaid Expenses
Receivables $13.38M $100.1M
Other Receivables $10.00K $10.30M
Total Short-Term Assets $62.45M $167.00 $74.24K
YoY Change 34284.61% -99.97% 122.28%
LONG-TERM ASSETS
Property, Plant & Equipment $255.0K $5.500M
YoY Change -65.17%
Goodwill $2.974M
YoY Change -85.94%
Intangibles
YoY Change
Long-Term Investments $220.0K $58.36M $58.08M
YoY Change -99.62% 0.48%
Other Assets $80.00K $500.0K
YoY Change -88.57% 1566.67%
Total Long-Term Assets $6.670M $58.36M $58.08M
YoY Change -88.51% 0.48%
TOTAL ASSETS
Total Short-Term Assets $62.45M $167.00 $74.24K
Total Long-Term Assets $6.670M $58.36M $58.08M
Total Assets $69.12M $58.36M $58.16M
YoY Change 18.64% -0.41% 174019.88%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $7.550M $63.70M
YoY Change -91.94%
Accrued Expenses $25.47K $21.00K $18.50K
YoY Change -32.07% -22.14% 16.13%
Deferred Revenue
YoY Change
Short-Term Debt $620.0K $191.7K $0.00
YoY Change -100.0%
Long-Term Debt Due $4.400M $500.0K
YoY Change
Total Short-Term Liabilities $13.18M $634.8K $394.3K
YoY Change 11642.53% 1056.24% 276.05%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $560.0K $2.155M $2.130M
YoY Change -72.84% 4.5%
Total Long-Term Liabilities $560.0K $2.155M $2.130M
YoY Change -72.84% 4.5%
TOTAL LIABILITIES
Total Short-Term Liabilities $13.18M $634.8K $394.3K
Total Long-Term Liabilities $560.0K $2.155M $2.130M
Total Liabilities $13.84M $2.790M $2.524M
YoY Change 536.56% 31.77% 2307.42%
SHAREHOLDERS EQUITY
Retained Earnings $16.59M -$2.832M
YoY Change -67.0%
Common Stock $5.081K $171.00
YoY Change -94.1%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $54.92M -$2.790M -$2.450M
YoY Change
Total Liabilities & Shareholders Equity $69.12M $58.36M $58.16M
YoY Change 18.64% -0.41% 174019.88%

Cashflow Statement

Concept 2022 Q3 2022 Q2 2022 Q1
OPERATING ACTIVITIES
Net Income $1.660M -$103.8K -$309.8K
YoY Change -521.06% -27.52% 445.71%
Depreciation, Depletion And Amortization $710.0K $1.600M $1.700M
YoY Change -58.24% 0.0% 0.0%
Cash From Operating Activities $5.140M -$30.82K -$229.9K
YoY Change -1071.96% -76.7% 443.21%
INVESTING ACTIVITIES
Capital Expenditures $260.0K $706.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities $2.440M -$44.57K -$990.00
YoY Change -364279.1% -99.92%
Cash From Investing Activities $2.190M -$44.57K -$990.00
YoY Change -326965.67% -99.92%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 32.73M 46.32K 211.1K
YoY Change 58545.4% -99.92% 677.63%
NET CHANGE
Cash From Operating Activities 5.140M -30.82K -229.9K
Cash From Investing Activities 2.190M -44.57K -990.0
Cash From Financing Activities 32.73M 46.32K 211.1K
Net Change In Cash 40.06M -29.07K -19.88K
YoY Change -8557.01% -105.74%
FREE CASH FLOW
Cash From Operating Activities $5.140M -$30.82K -$229.9K
Capital Expenditures $260.0K $706.00
Free Cash Flow $4.880M -$230.6K
YoY Change -1022.79% 444.88%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001841209
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
usd
CY2021Q4 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2021Q2 GPCO Other Unrelized Comprehensive Income Loss Available For Sale Securities Tax
OtherUnrelizedComprehensiveIncomeLossAvailableForSaleSecuritiesTax
usd
GPCO Other Unrelized Comprehensive Income Loss Available For Sale Securities Tax
OtherUnrelizedComprehensiveIncomeLossAvailableForSaleSecuritiesTax
usd
CY2021Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax
usd
us-gaap Other Comprehensive Income Loss Available For Sale Securities Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax
usd
CY2021Q1 us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
usd
GPCO Dividend Income Earned In Cash And Investments Held In Trust Account
DividendIncomeEarnedInCashAndInvestmentsHeldInTrustAccount
usd
GPCO Changes In Fair Value Of Warrant Liabilities
ChangesInFairValueOfWarrantLiabilities
usd
GPCO Proceeds Deposited In Trust Account
ProceedsDepositedInTrustAccount
usd
GPCO Dividend Income
DividendIncome
usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
usd
GPCO Initial Classification Of Ordinary Shares Subject To Possible Redemption
InitialClassificationOfOrdinarySharesSubjectToPossibleRedemption
usd
GPCO Allocation Of Offering Costs To Common Stock Subject To Redemption
AllocationOfOfferingCostsToCommonStockSubjectToRedemption
usd
GPCO Initial Recognition Of Warrant Liabilities
InitialRecognitionOfWarrantLiabilities
usd
GPCO Accrued Underwriting Compensation
AccruedUnderwritingCompensation
usd
GPCO Unrealized Gain On Availableforsale Securities
UnrealizedGainOnAvailableforsaleSecurities
usd
us-gaap Other Comprehensive Income Loss Available For Sale Securities Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax
usd
GPCO Proceeds Of Promissory Note Deposited In Trust Account By Founder Shareholder
ProceedsOfPromissoryNoteDepositedInTrustAccountByFounderShareholder
usd
CY2021 GPCO Available For Sale Equity Securities Gross Unrealized Holding Gain
AvailableForSaleEquitySecuritiesGrossUnrealizedHoldingGain
usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity Registrant Name
EntityRegistrantName
GOLDEN PATH ACQUISITION CORPORATION
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
E9
dei Entity File Number
EntityFileNumber
001-440519
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
00-0000000
dei Entity Address Address Line1
EntityAddressAddressLine1
100 Park Avenue
dei Entity Address City Or Town
EntityAddressCityOrTown
New York
dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10017
dei City Area Code
CityAreaCode
(917)
dei Local Phone Number
LocalPhoneNumber
267-4569
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
true
CY2022Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
7458000 shares
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
48955 usd
CY2022Q2 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
167 usd
CY2021Q4 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
95167 usd
CY2022Q2 us-gaap Assets Current
AssetsCurrent
167 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
144122 usd
CY2022Q2 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
58356044 usd
CY2021Q4 us-gaap Assets
Assets
58221185 usd
CY2022Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
21000 usd
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
41000 usd
CY2022Q2 us-gaap Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
191667 usd
CY2022Q2 GPCO Amount Due To Related Party
AmountDueToRelatedParty
422111 usd
CY2021Q4 GPCO Amount Due To Related Party
AmountDueToRelatedParty
164740 usd
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
634778 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
205740 usd
CY2022Q2 GPCO Warrants Liabilities
WarrantsLiabilities
717873 usd
CY2021Q4 GPCO Warrants Liabilities
WarrantsLiabilities
639990 usd
CY2022Q2 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
1437500 usd
CY2021Q4 us-gaap Deferred Compensation Liability Classified Noncurrent
DeferredCompensationLiabilityClassifiedNoncurrent
1437500 usd
CY2022Q2 us-gaap Liabilities
Liabilities
2790151 usd
CY2021Q4 us-gaap Liabilities
Liabilities
2283230 usd
CY2021Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
58077063 usd
CY2022Q2 us-gaap Assets
Assets
58356211 usd
CY2022Q2 us-gaap Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
5750000 shares
CY2021Q4 us-gaap Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
5750000 shares
CY2022Q2 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
10.15
CY2021Q4 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
10.10
CY2022Q2 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
58356044 usd
CY2021Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
58077063 usd
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1708000 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1708000 shares
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1708000 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1708000 shares
CY2022Q2 us-gaap Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
5750000 shares
CY2021Q4 us-gaap Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
5750000 shares
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
171 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
171 usd
CY2022Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
42173 usd
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
421 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2832328 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2139700 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-2789984 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-2139108 usd
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
58356211 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
58221185 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
122893 usd
CY2021Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
143280 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
381326 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
200059 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
122893 usd
CY2021Q2 us-gaap Operating Expenses
OperatingExpenses
143280 usd
us-gaap Operating Expenses
OperatingExpenses
381326 usd
us-gaap Operating Expenses
OperatingExpenses
200059 usd
CY2022Q2 GPCO Change In Fair Value Of Warrant Liabilities
ChangeInFairValueOfWarrantLiabilities
-25477 usd
CY2021Q2 GPCO Change In Fair Value Of Warrant Liabilities
ChangeInFairValueOfWarrantLiabilities
-0 usd
GPCO Change In Fair Value Of Warrant Liabilities
ChangeInFairValueOfWarrantLiabilities
-77883 usd
GPCO Change In Fair Value Of Warrant Liabilities
ChangeInFairValueOfWarrantLiabilities
-0 usd
CY2022Q2 us-gaap Dividend Income Operating
DividendIncomeOperating
44569 usd
CY2021Q2 us-gaap Dividend Income Operating
DividendIncomeOperating
68 usd
us-gaap Dividend Income Operating
DividendIncomeOperating
45562 usd
us-gaap Dividend Income Operating
DividendIncomeOperating
68 usd
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
19092 usd
CY2021Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
68 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-32321 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
68 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-103801 usd
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-143212 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-413647 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-199991 usd
CY2022Q2 us-gaap Profit Loss
ProfitLoss
-103801 usd
CY2021Q2 us-gaap Profit Loss
ProfitLoss
-143212 usd
us-gaap Profit Loss
ProfitLoss
-413647 usd
us-gaap Profit Loss
ProfitLoss
-199991 usd
CY2022Q2 GPCO Other Unrelized Comprehensive Income Loss Available For Sale Securities Tax
OtherUnrelizedComprehensiveIncomeLossAvailableForSaleSecuritiesTax
-42173 usd
GPCO Other Unrelized Comprehensive Income Loss Available For Sale Securities Tax
OtherUnrelizedComprehensiveIncomeLossAvailableForSaleSecuritiesTax
-45920 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Available For Sale Securities Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax
4168 usd
us-gaap Other Comprehensive Income Loss Available For Sale Securities Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax
4168 usd
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-65796 usd
CY2021Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-143212 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-371895 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-199991 usd
CY2022Q2 GPCO Basic And Diluted Weighted Average Shares Outstanding Ordinary Shares Subject To Possible Redemption
BasicAndDilutedWeightedAverageSharesOutstandingOrdinarySharesSubjectToPossibleRedemption
5750000 shares
CY2021Q2 GPCO Basic And Diluted Weighted Average Shares Outstanding Ordinary Shares Subject To Possible Redemption
BasicAndDilutedWeightedAverageSharesOutstandingOrdinarySharesSubjectToPossibleRedemption
5750000 shares
GPCO Basic And Diluted Weighted Average Shares Outstanding Ordinary Shares Subject To Possible Redemption
BasicAndDilutedWeightedAverageSharesOutstandingOrdinarySharesSubjectToPossibleRedemption
5750000 shares
GPCO Basic And Diluted Weighted Average Shares Outstanding Ordinary Shares Subject To Possible Redemption
BasicAndDilutedWeightedAverageSharesOutstandingOrdinarySharesSubjectToPossibleRedemption
5750000 shares
CY2022Q2 GPCO Basic And Diluted Net Loss Per Share Ordinary Shares Subject To Possible Redemption
BasicAndDilutedNetLossPerShareOrdinarySharesSubjectToPossibleRedemption
-0.00
CY2021Q2 GPCO Basic And Diluted Net Loss Per Share Ordinary Shares Subject To Possible Redemption
BasicAndDilutedNetLossPerShareOrdinarySharesSubjectToPossibleRedemption
0.17
GPCO Basic And Diluted Net Loss Per Share Ordinary Shares Subject To Possible Redemption
BasicAndDilutedNetLossPerShareOrdinarySharesSubjectToPossibleRedemption
-0.04
GPCO Basic And Diluted Net Loss Per Share Ordinary Shares Subject To Possible Redemption
BasicAndDilutedNetLossPerShareOrdinarySharesSubjectToPossibleRedemption
0.16
CY2022Q2 GPCO Basic And Diluted Weighted Average Shares Outstanding Ordinary Shares Attributable To Golden Path Acquisition Corporation
BasicAndDilutedWeightedAverageSharesOutstandingOrdinarySharesAttributableToGoldenPathAcquisitionCorporation
1708000 shares
CY2021Q2 GPCO Basic And Diluted Weighted Average Shares Outstanding Ordinary Shares Attributable To Golden Path Acquisition Corporation
BasicAndDilutedWeightedAverageSharesOutstandingOrdinarySharesAttributableToGoldenPathAcquisitionCorporation
1455335 shares
GPCO Basic And Diluted Weighted Average Shares Outstanding Ordinary Shares Attributable To Golden Path Acquisition Corporation
BasicAndDilutedWeightedAverageSharesOutstandingOrdinarySharesAttributableToGoldenPathAcquisitionCorporation
1708000 shares
GPCO Basic And Diluted Weighted Average Shares Outstanding Ordinary Shares Attributable To Golden Path Acquisition Corporation
BasicAndDilutedWeightedAverageSharesOutstandingOrdinarySharesAttributableToGoldenPathAcquisitionCorporation
1446467 shares
CY2022Q2 GPCO Basic And Diluted Net Loss Per Share Ordinary Shares Attributable To Golden Path Acquisition Corporation
BasicAndDilutedNetLossPerShareOrdinarySharesAttributableToGoldenPathAcquisitionCorporation
-0.05
CY2021Q2 GPCO Basic And Diluted Net Loss Per Share Ordinary Shares Attributable To Golden Path Acquisition Corporation
BasicAndDilutedNetLossPerShareOrdinarySharesAttributableToGoldenPathAcquisitionCorporation
-0.76
GPCO Basic And Diluted Net Loss Per Share Ordinary Shares Attributable To Golden Path Acquisition Corporation
BasicAndDilutedNetLossPerShareOrdinarySharesAttributableToGoldenPathAcquisitionCorporation
-0.09
GPCO Basic And Diluted Net Loss Per Share Ordinary Shares Attributable To Golden Path Acquisition Corporation
BasicAndDilutedNetLossPerShareOrdinarySharesAttributableToGoldenPathAcquisitionCorporation
-0.77
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-2139108 usd
CY2022Q1 GPCO Unrealized Gain On Availableforsales Securities
UnrealizedGainOnAvailableforsalesSecurities
3747 usd
CY2022Q1 GPCO Accretion Of Carrying Value To Redemptions Value
AccretionOfCarryingValueToRedemptionsValue
-4740 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-309846 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-2449947 usd
CY2022Q2 GPCO Unrealized Gain On Availableforsales Securities
UnrealizedGainOnAvailableforsalesSecurities
42173 usd
CY2022Q2 GPCO Realized Holding Gain On Availableforsales Securities
RealizedHoldingGainOnAvailableforsalesSecurities
-4168 usd
CY2022Q2 GPCO Accretion Of Carrying Value To Redemptions Value
AccretionOfCarryingValueToRedemptionsValue
-274241 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-103801 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-2789984 usd
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-39667 usd
CY2021Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
25000 usd
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-56779 usd
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-71446 usd
CY2021Q2 GPCO Sale Of Units In Initial Public Offering
SaleOfUnitsInInitialPublicOffering
57500000 usd
CY2021Q2 GPCO Sale Of Units To Founder In Private Placement
SaleOfUnitsToFounderInPrivatePlacement
2705000 usd
CY2021Q2 GPCO Offering Costs
OfferingCosts
-2887500 usd
CY2021Q2 GPCO Warrant Liabilities
WarrantLiabilities
-625000 usd
CY2021Q2 GPCO Initial Classification Of Common Stock Subject To Possible Redemption
InitialClassificationOfCommonStockSubjectToPossibleRedemption
-55511039 usd
CY2021Q2 GPCO Allocation Of Offering Costs To Common Stock Subject To Possible Redemption
AllocationOfOfferingCostsToCommonStockSubjectToPossibleRedemption
2787620 usd
CY2021Q2 GPCO Accretion Of Carrying Value To Redemptions Value
AccretionOfCarryingValueToRedemptionsValue
-5351581 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-143213 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-1597159 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
413647 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
199991 usd
GPCO Dividend Income Earned In Cash And Investments Held In Trust Account
DividendIncomeEarnedInCashAndInvestmentsHeldInTrustAccount
68 usd
GPCO Changes In Fair Value Of Warrant Liabilities
ChangesInFairValueOfWarrantLiabilities
-77883 usd
us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
-95000 usd
us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
1601 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-20000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
26966 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-260764 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-174694 usd
GPCO Proceeds Deposited In Trust Account
ProceedsDepositedInTrustAccount
58075002 usd
GPCO Dividend Income
DividendIncome
-45562 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-45562 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-58075002 usd
us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
257371 usd
us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
-8853 usd
GPCO Increase In Cash Held In Escrow
IncreaseInCashHeldInEscrow
-9000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
25000 usd
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
57500000 usd
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
2705000 usd
GPCO Payment Of Offering Costs
PaymentOfOfferingCosts
1421000 usd
us-gaap Repayments Of Debt
RepaymentsOfDebt
50000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
257371 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
58741147 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-48955 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
491451 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
48955 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
18117 usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
509568 usd
GPCO Initial Classification Of Ordinary Shares Subject To Possible Redemption
InitialClassificationOfOrdinarySharesSubjectToPossibleRedemption
55511039 usd
GPCO Allocation Of Offering Costs To Common Stock Subject To Redemption
AllocationOfOfferingCostsToCommonStockSubjectToRedemption
2787620 usd
GPCO Accretion Of Carrying Value To Redemption Value
AccretionOfCarryingValueToRedemptionValue
-278981 usd
GPCO Accretion Of Carrying Value To Redemption Value
AccretionOfCarryingValueToRedemptionValue
-5351581 usd
GPCO Initial Recognition Of Warrant Liabilities
InitialRecognitionOfWarrantLiabilities
625000 usd
GPCO Accrued Underwriting Compensation
AccruedUnderwritingCompensation
1437500 usd
GPCO Unrealized Gain On Availableforsale Securities
UnrealizedGainOnAvailableforsaleSecurities
42173 usd
us-gaap Other Comprehensive Income Loss Available For Sale Securities Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesTax
4168 usd
GPCO Proceeds Of Promissory Note Deposited In Trust Account By Founder Shareholder
ProceedsOfPromissoryNoteDepositedInTrustAccountByFounderShareholder
191687 usd
GPCO Transaction Costs
TransactionCosts
2887500 usd
us-gaap Expense Related To Distribution Or Servicing And Underwriting Fees
ExpenseRelatedToDistributionOrServicingAndUnderwritingFees
1150000 usd
GPCO Deferred Underwriting Fees
DeferredUnderwritingFees
1437500 usd
CY2022Q2 us-gaap Other Ownership Interests Offering Costs
OtherOwnershipInterestsOfferingCosts
300000 usd
CY2022Q2 GPCO Cash Held In Trust Account
CashHeldInTrustAccount
0 usd
CY2021Q2 GPCO Proceeds From Ipo And Private Placement
ProceedsFromIpoAndPrivatePlacement
58075002 usd
GPCO Percentage Of Asset Held In Trust Account
PercentageOfAssetHeldInTrustAccount
0.80 pure
CY2022Q2 GPCO Business Combination Percentage Of Voting Securities
BusinessCombinationPercentageOfVotingSecurities
0.50 pure
CY2022Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
5000001 usd
CY2021Q3 GPCO Acquisition Merger Amount
AcquisitionMergerAmount
450000000 usd
CY2021Q3 us-gaap Shares Issued
SharesIssued
44554455 shares
CY2021Q3 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
10.10
GPCO Number Of Merger Common Stock Received
NumberOfMergerCommonStockReceived
44554455 shares
CY2022Q2 us-gaap Deposits
Deposits
191667 usd
GPCO Aggregate Amount
AggregateAmount
1725000 usd
us-gaap Interest Expense
InterestExpense
50000 usd
GPCO Initial Public Offering Price Per Unit
InitialPublicOfferingPricePerUnit
10.00 usd
CY2022Q2 GPCO Working Capital Deficit
WorkingCapitalDeficit
634611 usd
us-gaap Profit Loss
ProfitLoss
-413647 usd
CY2022Q2 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0 usd
CY2021Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_844_eus-gaap--UseOfEstimates_ziVEIzB41OL8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 0"/><td style="width: 27pt">●</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_860_zhX92zpBeEbh">Use of estimates</span></span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results may differ from those estimates.</p>
CY2022Q2 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
58356044 usd
CY2021Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
58077063 usd
CY2022Q2 us-gaap Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
5750000 shares
CY2021Q4 us-gaap Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
5750000 shares
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_841_eus-gaap--ConcentrationRiskCreditRisk_zE3lQ3YwXVGk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 0"/><td style="width: 27pt">●</td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif"><span id="xdx_861_zILYswV5gXK2">Concentration of credit risk</span></span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Financial instruments that potentially subject the Company to concentration of credit risk consist of cash and trust accounts in a financial institution which, at times may exceed the Federal depository insurance coverage of $<span id="xdx_900_eus-gaap--CashFDICInsuredAmount_c20220630_pp0p0" title="Federal depository insurance coverage">250,000</span>. The Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.</p>
CY2022Q2 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000 usd
CY2022Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 usd
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 usd
CY2022Q2 us-gaap Income Tax Examination Penalties And Interest Accrued
IncomeTaxExaminationPenaltiesAndInterestAccrued
0 usd
CY2021Q4 us-gaap Income Tax Examination Penalties And Interest Accrued
IncomeTaxExaminationPenaltiesAndInterestAccrued
0 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
413647 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
199991 usd
GPCO Accretion Of Carrying Value To Redemption Values
AccretionOfCarryingValueToRedemptionValues
-278981 usd
GPCO Accretion Of Carrying Value To Redemption Values
AccretionOfCarryingValueToRedemptionValues
-5351581 usd
GPCO Net Loss Including Accretion Of Carrying Value To Redemption Value
NetLossIncludingAccretionOfCarryingValueToRedemptionValue
-692628 usd
GPCO Net Loss Including Accretion Of Carrying Value To Redemption Value
NetLossIncludingAccretionOfCarryingValueToRedemptionValue
-5551572 usd
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
103801 usd
CY2021Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
143212 usd
CY2022Q2 GPCO Accretion Of Carrying Value To Redemption Values
AccretionOfCarryingValueToRedemptionValues
-274241 usd
CY2021Q2 GPCO Accretion Of Carrying Value To Redemption Values
AccretionOfCarryingValueToRedemptionValues
-5351581 usd
CY2022Q2 GPCO Net Loss Including Accretion Of Carrying Value To Redemption Value
NetLossIncludingAccretionOfCarryingValueToRedemptionValue
-378042 usd
CY2021Q2 GPCO Net Loss Including Accretion Of Carrying Value To Redemption Value
NetLossIncludingAccretionOfCarryingValueToRedemptionValue
-5494793 usd
CY2022Q2 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
58356044 usd
CY2022Q2 us-gaap Cash
Cash
0 usd
CY2022Q2 GPCO Carrying Value Of Assets Held In Trust
CarryingValueOfAssetsHeldInTrust
58313871 usd
GPCO Available For Sale Equity Securities Gross Unrealized Holding Gain
AvailableForSaleEquitySecuritiesGrossUnrealizedHoldingGain
42173 usd
CY2022Q2 us-gaap Assets Held In Trust
AssetsHeldInTrust
58356044 usd
CY2021Q4 GPCO Carrying Value Of Assets Held In Trust
CarryingValueOfAssetsHeldInTrust
58077063 usd
CY2021Q4 us-gaap Assets Held In Trust
AssetsHeldInTrust
58077063 usd
CY2021Q2 us-gaap Affiliate Costs
AffiliateCosts
10000 usd
CY2022Q2 us-gaap Deposits
Deposits
191667 usd
GPCO Aggregate Amount
AggregateAmount
1725000 usd
CY2022Q2 us-gaap Unsecured Debt
UnsecuredDebt
191667 usd
CY2022Q3 us-gaap Unsecured Debt
UnsecuredDebt
191667 usd
CY2022Q2 us-gaap Notes Payable
NotesPayable
191667 usd
CY2021Q4 us-gaap Notes Payable
NotesPayable
0 usd
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
us-gaap Common Stock Voting Rights
CommonStockVotingRights
Holders of the ordinary shares are entitled to one vote for each ordinary share.
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1708000 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1708000 shares
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1708000 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1708000 shares
CY2022Q2 us-gaap Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
5750000 shares
CY2021Q4 us-gaap Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
5750000 shares
CY2021Q2 GPCO Initial Fair Value
InitialFairValue
625000 usd
CY2022Q2 us-gaap Share Price
SharePrice
9.91
CY2021Q4 us-gaap Share Price
SharePrice
9.96
CY2021Q2 us-gaap Share Price
SharePrice
10.00
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0301 pure
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0126 pure
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0090 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.6320 pure
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.5980 pure
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.5840 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
0.1150
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
0.1150
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
0.1150
GPCO Warrant Life
WarrantLife
P5Y
CY2021 GPCO Warrant Life
WarrantLife
P5Y
CY2021Q2 GPCO Warrant Life
WarrantLife
P5Y
CY2022Q2 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
718000 usd
GPCO Change In Fair Value Of Warrant Liabilities
ChangeInFairValueOfWarrantLiabilities
-77883 usd
CY2022Q2 GPCO Change In Fair Value Of Warrant Liabilities
ChangeInFairValueOfWarrantLiabilities
-25477 usd
CY2021Q2 GPCO Change In Fair Value Of Warrant Liabilities
ChangeInFairValueOfWarrantLiabilities
-0 usd

Files In Submission

Name View Source Status
0001829126-22-015807-index-headers.html Edgar Link pending
0001829126-22-015807-index.html Edgar Link pending
0001829126-22-015807.txt Edgar Link pending
0001829126-22-015807-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
goldenpath_10q.htm Edgar Link pending
goldenpath_ex10-1.htm Edgar Link pending
goldenpath_10q_htm.xml Edgar Link completed
goldenpath_ex31-1.htm Edgar Link pending
goldenpath_ex31-2.htm Edgar Link pending
goldenpath_ex32-1.htm Edgar Link pending
goldenpath_ex32-2.htm Edgar Link pending
gpco-20220630.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
gpco-20220630_cal.xml Edgar Link unprocessable
gpco-20220630_pre.xml Edgar Link unprocessable
gpco-20220630_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
gpco-20220630_def.xml Edgar Link unprocessable